-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vj2UxbfBssBEwueFFkmAq6USKyGxOSOprw5xmdZWJeCQ3iMV3601Lxp5sfqFJIjN u5zSYtqeUbFVXCCL9/qRrQ== 0001061983-10-000011.txt : 20100226 0001061983-10-000011.hdr.sgml : 20100226 20100226171037 ACCESSION NUMBER: 0001061983-10-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100224 FILED AS OF DATE: 20100226 DATE AS OF CHANGE: 20100226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOLFF ANDREW A CENTRAL INDEX KEY: 0001238406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 10640526 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-02-24 0 0001061983 CYTOKINETICS INC CYTK 0001238406 WOLFF ANDREW A 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP Clinical R&D, CMO Common Stock 5000 D Incentive Stock Option (right to buy) 3.08 2010-02-24 4 A 0 42084 0 A 2010-03-24 2020-02-24 Common Stock 42084 42084 D Non-Qualified Stock Option (right to buy) 3.08 2010-02-24 4 A 0 92916 0 A 2010-03-24 2020-02-24 Common Stock 92916 92916 D Incentive Stock Option (right to buy) 1.85 2009-03-26 2019-02-26 Common Stock 37917 37917 D Incentive Stock Option (right to buy) 3.37 2008-03-29 2018-02-28 Common Stock 27935 27935 D Incentive Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 781 781 D Incentive Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 14185 14185 D Incentive Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 17019 17019 D Incentive Stock Option (right to buy) 9.91 2005-09-20 2014-10-20 Common Stock 40360 40360 D Non-Qualified Stock Option (right to buy) 1.85 2009-03-26 2019-02-26 Common Stock 92083 92083 D Non-Qualified Stock Option (right to buy) 3.37 2008-03-29 2018-02-28 Common Stock 97065 97065 D Non-Qualified Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 11719 11719 D Non-Qualified Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 40815 40815 D Non-Qualified Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 42981 42981 D Non-Qualified Stock Option (right to buy) 9.91 2005-09-20 2014-10-20 Common Stock 69640 69640 D When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014. When the ISO and NQ dated 02/26/2009 are combined for a total grant of 130,000 shares, the option shall vest and become exercisable as to 2,708 shares on 03/26/09 and the balance of 127,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13. When the ISO and NQ dated 02/29/2008 are combined for a total grant of 125,000 shares, the option shall vest and become exercisable as to 2,604 shares on 03/29/08 and the balance of 122,396 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12. When the ISO and NQ dated 04/11/05 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 12,500 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009. When the ISO and NQ dated 03/14/2007 are combined for a total grant of 55,000 shares, the option shall vest and become exercisable as to 1,146 shares on 04/01/07 and the balance of 53,854 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11. When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010. When the ISO and NQ dated 10/20/04 are combined for a total grant of 110,000 shares, the option shall vest and become exercisable as to 27,500 shares on 09/20/05 and the balance of 82,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 09/20/08. Andrew A. Wolff, M.D. 2010-02-25 -----END PRIVACY-ENHANCED MESSAGE-----